English | Español

Technology/Innovation
+ Technology/Innovation
Jamie Barrand | Oct 16, 2015

Ocrelizumab shows promise against MS in three Phase III studies
+ Regulatory
Jamie Barrand | Oct 15, 2015

Lawmakers request delay in Stage 3 EHR program
+ Technology/Innovation
Jamie Barrand | Oct 14, 2015

Allergan releasing generic version of Invega in U.S.
+ Regulatory
Jamie Barrand | Oct 14, 2015

Glytec receives Notice of Allowance from U.S. Patent and Trademark Office
Jamie Barrand | Oct 14, 2015

Study uncovers immune system biomarkers for HIV treatment
+ Technology/Innovation
Jamie Barrand | Oct 14, 2015

FDA approves two diabetes treatments
Wendell Hutson | Oct 13, 2015

Study finds anesthesia complications in cesarean deliveries are down
Jamie Barrand | Oct 13, 2015

Health Council, Genetic Alliance release report on doctor-patient engagement

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'